98%
921
2 minutes
20
Temperature-responsive liquid chromatography (TRLC) offers an alternative for retention and selectivity optimisation in HPLC. This approach thereby exploits temperature gradients on stimuli-responsive stationary phases and forfeits the necessity for solvent gradients, allowing analyses to be performed using aqueous mobile phases. Consequently, it can be employed as a green alternative to reversed-phase separations. However, current production to obtain temperature-responsive columns inherently require dedicated column packing processes with polymer-modified particles. To facilitate the development of temperature-responsive phases, a flow-through modification procedure was developed allowing on-column modification of aminopropyl silica columns. Three columns were manufactured using this novel flow-through approach, which achieved identical column efficiencies compared to existing TRLC column. Demonstrating the possibility of bypassing the dedicated packing processes without losing efficiency. Additionally, it was observed that flow-through produced columns yielded higher retention at elevated temperatures despite their reduced carbon load. Further investigation of the carbon load revealed the presence of stationary phase gradients, whose influence was studied via novel developed retention experiments, which revealed a negligible change reduction in retention upon a change of polymer modification from 19.8% to 14.5%. However, further decrease from 14.5% to 12.3% resulted in a larger change. Interestingly, a further enhancement in apparent plate numbers was observed when operating the column under a reversed flow, yielding an increasing stationary phase gradient. This on-column modification procedure demonstrates the potential for modification of existing (commercial) packed columns to achieve temperature-responsive phases without loss of efficiency or retention. Thus, not only facilitating accessibility to temperature-responsive phases, but also aiding with development of further generations of temperature-responsive phases by removing the need for packing optimisation. Additionally, a novel experiment was set up to easily investigate the effect of inhomogeneous stationary phases retention.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.aca.2023.341961 | DOI Listing |
J Mater Chem B
September 2025
The Avram and Stella Goldstein Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, P.O.B. 653, Beer-Sheva 8410501, Israel.
The development of "smart" polymers capable of responding to physiologically relevant stimuli is essential for engineering dynamic sensing and actuation systems that leverage biological signals under specific (patho)physiological conditions. In this study, we present a general and versatile strategy to engineer novel stimuli-responsive behaviors in temperature-responsive protein-based polymers (PBPs) site-specific conjugation with self-immolative molecules. Specifically, we developed hydrogen peroxide (HO)- and β-galactosidase (β-gal)-responsive elastin-like polypeptides (ELPs) and resilin-like polypeptides (RLPs).
View Article and Find Full Text PDFACS Nano
September 2025
WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa 920-1192, Japan.
Thermogenetics uses temperature-sensitive proteins to regulate cellular functions via temperature changes. Compared to optogenetics, which utilizes visible light and is limited by light penetration, thermogenetics offers a practical alternative by enabling deeper and more accessible control of cellular processes via heat. Herein, we report the development of a thermogenetically controlled programmed cell death system that enables heat-activated human caspase 8 (CASP8) using temperature-responsive elastin-like polypeptides (ELPs).
View Article and Find Full Text PDFBiomaterials
August 2025
Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Shanghai Key Laboratory of Functional Materials Chemistry, Feringa Nobel Prize Scientist Joint Research Center, Institute of Fine Chemicals, Frontiers Science Center fo
In situ gels with tumor-targeted therapy often struggle with precise spatiotemporal drug release, compromising their efficacy in complex and heterogenous tumors. Here, we present a temperature-activated in situ hydrogel (PTT-Br@mPEG-PLGA and Gem@TCM-TK-PEG in chitosan and PF127 gel, denoted as PP + GC gel. Therein, the photothermal compound PTT-Br is fully named 6-bromo-1-ethyl-2-(2-(6-hydroxy-2,3-dihydro-1H-xanthen-4-yl)vinyl)quinolin-1-ium, while the reactive oxygen species (ROS)-responsive polymer TCM-TK-PEG is fully named tricyano methylene pyridine-thioketal-polyethylene glycol.
View Article and Find Full Text PDFFront Bioeng Biotechnol
August 2025
Department of Pediatric Surgery, Hong Qi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, China.
Articular cartilage injury is an important challenge in the field of orthopedics. Due to its unique characteristics of being vascularless, neuralless, and without lymphoid tissue, as well as the poor proliferation and migration ability of chondrocytes, the self-repair ability of cartilage after injury is limited. In recent years, with the development of tissue engineering, temperature-sensitive hydrogels, a new type of biomedical material, have unique temperature-responsive phase transition characteristics (such as a phase transition critical point close to the physiological temperature) that enable them to rapidly form a stable three-dimensional porous structure triggered by body temperature after being injected into the joint cavity.
View Article and Find Full Text PDFInt J Pharm
October 2025
Inner Mongolia Key Laboratory for Molecular Regulation of the Cell, School of Life Sciences, Inner Mongolia University, Hohhot 010020, China. Electronic address:
Glioblastoma (GBM), the most aggressive brain tumor, poses significant therapeutic challenges due to its infiltrative growth, resistance to conventional therapies, and the impermeable blood-brain barrier (BBB), which restricts drug delivery. To address these limitations, we developed a stimuli-responsive nanoplatform based on elastin-like polypeptides (ELPs)-biocompatible, thermally responsive biopolymers that enable precise drug release. The length-variable ELPs endow nanoparticles with tunable physicochemical characteristics, enabling the optimization of delivery efficiency through length-specific selection.
View Article and Find Full Text PDF